Insight

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Photo from Thomas Flaig/X

Apr 14, 2024, 06:07

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Thomas Flaig, Vice Chancellor for Research at University of Colorado Denver, shared on X/Twitter:

“Honored to be able to speak at the annual National Comprehensive Cancer Network meeting on the impact of recent research findings on the treatment of advanced bladder cancer – a busy time in the field with several updates to the NCCN bladder cancer guidelines.”

View additional information.
Source: Thomas Flaig/X

advanced bladder cancer Anschutz Medican Campus bladder cancer cancer National Comprehensive Cancer Network NCCN OncoDaily Oncology Thomas Flaig University of Colorado

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage